MHK
43
-2
AVB
34
-3
VZ
35
-2
MAT
50
-5
AEE
51
-7
IR
58
3
RCL
68
4
FSLR
73
15
AN
50
7
SNA
52
2
STT
62
3
UNP
38
2
HBAN
82
3
KSS
62
3
TXT
82
4
CNP
49
-6
DHR
66
2
FOX
68
2
GOOGL
47
4
PM
49
2
MHK
43
-2
AVB
34
-3
VZ
35
-2
MAT
50
-5
AEE
51
-7
IR
58
3
RCL
68
4
FSLR
73
15
AN
50
7
SNA
52
2
STT
62
3
UNP
38
2
HBAN
82
3
KSS
62
3
TXT
82
4
CNP
49
-6
DHR
66
2
FOX
68
2
GOOGL
47
4
PM
49
2
Financhill
Back

Freeport-McMoRan, Inc. Vs. Sarepta Therapeutics, Inc. Industry Stock Comparison

Buy
72

FCX
Freeport-McMoRan, Inc.

Last Price:
$49.13
Seasonality Move:
7.92%
Sell
42

SRPT
Sarepta Therapeutics, Inc.

Last Price:
$21.03
Seasonality Move:
10.38%
Buy
72
Freeport-McMoRan, Inc. (FCX) is a Buy

Is Freeport-McMoRan, Inc. a Buy, Sell or Hold?

  • The current Freeport-McMoRan, Inc. [FCX] share price is $49.15. The Score for FCX is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
  • FCX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
42
Sarepta Therapeutics, Inc. (SRPT) is a Sell

Is Sarepta Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Sarepta Therapeutics, Inc. [SRPT] share price is $21.04. The Score for SRPT is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FCX Stock Price Chart

What is Freeport-McMoRan, Inc.'s stock price today?

  • The Freeport-McMoRan, Inc. share price today is $49.15
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FCX is experiencing slight buying pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics, Inc.'s stock price today?

  • The Sarepta Therapeutics, Inc. share price today is $21.04
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing slight buying pressure.

FCX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.87 Buy
Relative Strength Index (14 RSI): 74.86 Buy
Chaikin Money Flow: 8327699 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (40.83 - 47.09) Buy
Bollinger Bands (100): (39.73 - 45.23) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.92 Buy
Relative Strength Index (14 RSI): 51.11 Buy
Chaikin Money Flow: 1527880 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (18.4 - 22.24) Buy
Bollinger Bands (100): (17.55 - 22.19) Buy

FCX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 47.74 Buy
20-day SMA: 44.95 Buy
50-day SMA: 42.55 Buy
200-day SMA: 41.03 Buy
8-day EMA: 47.51 Buy
20-day EMA: 45.55 Buy
50-day EMA: 43.58 Buy
200-day EMA: 42.07 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.48 Sell
20-day SMA: 21.06 Sell
50-day SMA: 20.78 Buy
200-day SMA: 32.06 Sell
8-day EMA: 11.03 Buy
20-day EMA: 5.4 Buy
50-day EMA: 2.36 Buy
200-day EMA: 0.62 Buy

Freeport-McMoRan, Inc. Earnings Growth & FCX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and an increase next year of $0.73 per share.

Sarepta Therapeutics, Inc. Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $1.60 per share, a decrease next quarter of $0.00 per share, a decrease this year of $6.03 per share, and an increase next year of $4.91 per share.

Freeport-McMoRan, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):